Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension

Current Opinion in Nephrology and Hypertension

Volumn 13, Issue 1, 2004, Pages 93-99

  Vaziri, Nosratola D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Atherosclerosis; Hypertension; Nicotinamide adenine dinucleotide phosphate (reduced form) oxidase; Oxidative stress; Reactive oxygen intermediates; Renal disease

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

BRAIN DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE CONTROL; DOWN REGULATION; ENDOTHELIUM INJURY; HUMAN; HYPERTENSION; INFLAMMATION; INTERSTITIAL NEPHRITIS; MACROPHAGE; METABOLITE; NITROSATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BRAIN; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, RENAL; INFLAMMATION; KIDNEY FAILURE, CHRONIC; NEPHRITIS, INTERSTITIAL; OXIDATIVE STRESS;

EID: 4043107129     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200401000-00013     Document Type: Review

References (48)

1. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62:1524-1538. A comprehensive review of evidence, potential causes, consequences and the proposed management of oxidative stress in patients with ESRD.
2. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 1998; 53:1748-1754.
3. Vaziri ND, Ni Z, Oveisi F, Liang K. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in chronic renal insufficiency. Hypertension 2002; 39:135-141. This study demonstrated the role of ROS-mediated NO inactivation and sequestration in the pathogenesis of uremic hypertension.
4. Hasdan G, Benchetrit S, Rashid G, Rathaus M. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 2002; 61:586-590. This study demonstrated the efficacy of SOD in reversing endothelial dysfunction in CRF animals.
5. Deng G, Vaziri ND, Jabbari B, Yan XX. Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy. J Am Soc Nephrol 2001; 12:1892-1898.
6. Shainkin-Kestenbaum R, Caruso C, Berlyne GM. Reduced superoxide dismutase activity in erythrocytes of dialysis patients: a possible factor in the etiology of uremic anemia. Nephron 1990; 55:251-253.
7. Durak I, Akyol O, Basesme E, et al. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66:76-80.
8. Eschbach JW, Adamson JW. Anemia of end-stage renal disease (ESRD). Kidney Int 1985; 28:1-5.
9. Turi S, Nemeth I, Vargha I, et al. Erythrocyte defense mechanisms against free oxygen radicals in haemodialysed uraemic children. Pediatr Nephrol 1991; 5:179-183.
10. Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000; 58:2571-2578.
11. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86:494-501.
12. Vaziri ND, Dicus M, Ho ND, Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase, NADPH oxidase and xanthine oxidase in renal insufficiency. Kidney Int 2003; 63:179-185. This was the first study demonstrating the role of NADPH oxidase and SOD deficiency in the pathogenesis of CRF-induced oxidative stress and hypertension.
13. Vaziri ND, Freel RW, Hatch M. Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol 1995; 6:1313-1317.
14. Vaziri ND, Ni Z, Wang XQ, et al. Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol Renal Physiol 1998; 274:642-649.
15. Don BR, Kaysen GA. Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol 2000; 13:249-259.
16. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002; 15:329-337.
17. Vaziri ND. Pathogenesis of lead-induced hypertension: role of oxidative stress. Am J Hypertens 2002; 20:315-320. This article provides an in-depth review of the role of oxidative stress in the pathogenesis of lead-induced hypertension.
18. Vaziri ND, Liang K, Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999; 56:1492-1498.
19. Ding Y, Gonick HC, Vaziri ND. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 2000; 13:552-555.
20. Ding Y, Gonick HC, Vaziri ND, et al. Lead-induced hypertension: increased hydroxyl radical production. Am J Hypertens 2001; 14:169-173.
21. Vaziri ND, Ding Y. Effect of lead on NO synthase expression in coronary endothelial cells: role of superoxide. Hypertension 2001; 37:223-226.
22. Vaziri ND, Lin CY, Farmand F, Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NAD(P)H oxidase in lead-induced hypertension. Kidney Int 2003; 63:186-194.
23. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, oxidative stress and nitric oxide availability. Circulation 2002; 106:2530-2532. This study demonstrated that a diet high in natural antioxidant (fruits and vegetables) together with daily exercise (walking) lowers oxidative stress, improves NO availability and ameliorates hypertension within a few weeks (despite minimal weight reduction) in a group of patients with the metabolic syndrome.
24. Roberts CK, Vaziri ND, Wang XQ, et al. Enhanced NO inactivation induced by a high fat, refined-carbohydrate diet. Hypertension 2000; 36:423-429.
25. Koo JR, Vaziri ND. Effect of diabetes insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003; 63:195-201. This study demonstrated that molecular targets of oxidative stress shift dramatically among untreated and insulin-treated diabetic animals, thus high-lighting the need to explore multiple markers in an assessment of oxidative stress in this and perhaps other conditions. The study further showed that when given in conjunction with insulin, antioxidant therapy can afford significant benefit in diabetic animals.
26. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32:59-64.
27. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin f2 alpha. Hypertension 1999; 33:424-428.
28. Vaziri ND, Ni Z, Oveisi F, et al. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000; 36:957-964.
29. Chen X, Touyz RM, Park JB, Schifrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38:606-611.
30. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 2001; 38:1044-1048.
31. Girouard H, Chulak C, Wu L, et al. N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats. Am J Hypertens 2003; 16:577-584.
32. Nava M, Quiroz Y, Vaziri ND, et al. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2003; 284:447-454. This study demonstrated an upregulation of NFκB and an accumulation of activated T cells, macrophages, superoxide-producing and angiotensin 2-positive cells in the tubulointerstitial region of the SHR kidney. The study further showed a substantial improvement in hypertension together with a reversal of these changes with antioxidant therapy (melatonin). The study thus established the role of oxidative stress in renal inflammation in SHRs.
33. Rodríguez-Iturbe B, Zhan CD, Quiroz Y, et al. Antioxidant-rich diet improves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003; 41:341-346. This study confirmed the results of the earlier study (Ref. [32••]) using a combination of vitamin E, vitamin C, zinc and selenium.
34. Chabrashvili T, Tojo A, Onozato ML, et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 2002; 39:269-274. This was the first study to demonstrate the upregulation of NADPH oxidase, NOX-1 and nephrox in the SHR kidney as a source of ROS.
35. Nicod L, Rodriguez S, Letang JM, et al. Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague Dawley rats. Mol Cell Biochem 2000; 203:33-39.
36. Beswick RA, Zhang H, Marable D, et al. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001; 37:781-786.
37. Barton M, Vos I, Shaw S, et al. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol 2000; 11:835-846.
38. Meng S, Roberts LJ, Cason GW, et al. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and resistant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R732-R738.
39. Lenda DM, Boegehold MA. Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol Heart Circ Physiol 2002; 282:H385-H402.
40. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36:142-146.
41. Zhou XJ, Vaziri ND, Wang XQ, et al. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 2002; 300:762-767.
42. 2 leads to hypertension. Hypertension 2003; 42:25-30.
43. Barton CH, Ni Z, Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 2001; 60:1083-1087.
44. Rodriguez-Iturbe B, Quiroz Y, Nava M, et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282:F191-F201.
45. Rodriguez-Iturbe B, Pons H, Quiroz Y, et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001; 59:2222-2232.
46. Rodriguez-Iturbe B, Quiroz Y, Nava M, et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282:F191-F201.
47. Rodriguez-Iturbe B, Quiroz Y, Herrera-Acosta J, et al. The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension. J Hypertens 2002; 20 (Suppl 3):S9-S14. An excellent review of the role of renal tubulointerstitial inflammation in the pathogenesis of salt-sensitive hypertension.
48. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomized placebo-controlled trial. Lancet 2000; 356:1213-1218.